Zelira Therapeutics's total assets for Q4 2025 were AU$1.30M, a decrease of -45.47% from the previous quarter. ZLDAF total liabilities were AU$5.59M for the fiscal quarter, a -46.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.